BTTAA provides greater rate enhancement than the previous generation ligands THPTA or TBTA. It is the latest generation of water-soluble accelerating ligands for CuAAC, and more importantly, it can achieve effective bioconjugation and inhibit cytotoxicity by further reducing the copper loading in the catalyst formulation. Interference with the physiological state of the body is minimized.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.